Bionano Announces Presentation of Optical Genome Mapping (OGM) Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting

• Dr. Alka Chaubey, chief medical officer at Bionano, will host a sponsored vendor panel presentation on the integration of OGM for clinical research in cancer, featuring cancer genomics experts Dr. Ravindra Kolhe, Augusta University, Dr. Yassmine Akkari, Nationwide Children’s Hospital, Dr. Susan Crocker, Kingston Health Sciences Centre/ Queen’s University, and Dr. Sachin Jadhav, HCG Network
• Thirteen scientific platform and poster presentations will illustrate the application of Bionano’s OGM workflow in research areas including solid tumors, hematological malignancies, leukemia and basophilia
• Bionano will introduce the latest products in the company’s OGM workflow to conference attendees, including Ionic G2 kits for the Ionic Purification System, featuring new chemistry for nucleic acid extraction from formalin-fixed paraffin-embedded (FFPE) and tumor tissue, and VIA software for hematological malignancies, which offers a simple and integrated workflow for visualization, interpretation and reporting across OGM, microarray and next-generation sequencing (NGS) data
• Bionano is a Diamond Sponsor at the conference, and will host conference attendees, customers, KOLs, and VIPs from the genomics and cytogenetics communities at an evening reception

SAN DIEGO, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting with a broad range of content covering the utility of optical genome mapping (OGM) for solid tumor and hematological malignancy cancer research, including scientific platform and poster presentations from Bionano and a panel discussion featuring esteemed researchers from across the cancer genomics landscape.

CGC’s annual meeting brings together industry, medical, and academic professionals to discuss advances in clinical genomics for oncology research. CGC conference sessions will be held August 13-16, 2023, online and in-person in St. Louis, Missouri.

As part of a sponsored spotlight panel, Bionano’s chief medical officer, Dr. Alka Chaubey, will host a discussion titled “Unleashing Genomic Insights That Matter with Optical Genomic Mapping: An Interactive Panel Discussion,” featuring cancer genomics experts Dr. Ravindra Kolhe, from the Medical College of Georgia/Augusta University, Dr. Yassmine Akkari, from Nationwide Children’s Hospital, Dr. Susan Crocker, from Kingston Health Sciences Centre/ Queen’s University, and Dr. Sachin Jadhav, from HCG Network. During this interactive session, experts will discuss their experience implementing OGM, key applications, and potential implications for future clinical research and medical guidelines. The presentation will take place Monday, August 14, from 12:30-1:00 PM CDT in the General Session room at the conference.